サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1739311

人工知能ベース医療診断ツールの世界市場

Artificial Intelligence-based Medical Diagnostic Tools

出版日
ページ情報
英文 182 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.12円
人工知能ベース医療診断ツールの世界市場
出版日: 2025年06月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

人工知能ベース医療診断ツールの世界市場は2030年までに48億米ドルに達する

2024年に17億米ドルと推定される人工知能ベース医療診断ツールの世界市場は、2024年から2030年にかけてCAGR 19.0%で成長し、2030年には48億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるAIソフトウェアは、CAGR 19.6%を記録し、分析期間終了時には23億米ドルに達すると予測されます。AIサービス分野の成長率は、分析期間でCAGR 17.4％と推定されます。

米国市場は4億4,570万米ドルと推定、中国はCAGR17.9％で成長予測

米国の人工知能ベース医療診断ツール市場は、2024年には4億4,570万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに7億3,930万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは17.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ17.4％と16.3％と予測されています。欧州では、ドイツがCAGR約12.9%で成長すると予測されています。

世界の人工知能ベース医療診断ツール市場- 主要動向と促進要因まとめ

なぜAIベースの診断ツールが医療意思決定シーンを再構築しているのか？

人工知能ベース医療診断ツールは、幅広い医療分野において、迅速かつ正確でスケーラブルな診断サポートを提供することで、臨床ワークフローとヘルスケア提供を変革しています。これらのツールは、機械学習（ML）、ディープラーニング、自然言語処理（NLP）を活用して、放射線画像、病理スライド、ゲノム配列、電子カルテ（EHR）、臨床検査結果などの多様な臨床データを分析し、従来の方法よりも高い一貫性とスピードで、パターンの特定、異常の検出、鑑別診断の生成を行います。世界中のヘルスケアシステムが、患者数の増加、労働力不足、精密医療の需要に取り組む中、AIを活用した診断は、診断精度を向上させ、ケアのばらつきを低減するために不可欠な補助ツールとして台頭しています。

静的なルールセットに依存する従来の意思決定支援システムとは異なり、AIツールは、しばしば専門家によって注釈が付けられた大規模なデータセットで学習することによって継続的に学習・進化し、エビデンスに基づく洞察をリアルタイムで提供します。これらのシステムは、病気の早期発見、トリアージ、リスク層別化をサポートするために、放射線検査室、病理検査室、プライマリケア診療所、遠隔医療プラットフォームに統合されつつあります。腫瘍学、循環器学から眼科、皮膚科に至るまで、AIは複雑な病態の迅速な特定を可能にし、診断の遅れを減らし、臨床の生産性を高め、患者の転帰を改善するタイムリーな介入を促進しています。

AIアルゴリズムは、画像診断、ゲノム解析、マルチモーダルデータの診断パフォーマンスをどのように向上させているか？

AIベースの診断ツールは、CTスキャン、MRI、X線、マンモグラム、超音波画像を高精度で解釈することで、医療画像診断に革命をもたらしています。深層畳み込みニューラルネットワーク（CNN）は、画像セグメンテーション、特徴抽出、病変分類に広く使用されており、肺結節検出、乳がんスクリーニング、糖尿病網膜症の等級付けなどの特定のタスクにおいて、しばしば人間の専門家よりも優れています。これらのツールは、画像判読を高速化するだけでなく、ヒートマップや説明可能な機能によって異常を強調し、臨床的信頼性とワークフロー統合を向上させる。

ゲノミクス分野では、AIが複雑な遺伝子データの解読を支援し、疾病リスク予測、希少疾病診断、腫瘍学における治療法選択に役立っています。自然言語処理アルゴリズムは、構造化されていないEHR、検査報告書、臨床ノートから臨床に関連するデータを抽出し、包括的な患者プロファイルを作成し、手動レビューでは見逃される可能性のある診断シグナルを検出します。画像診断、検査値、遺伝子マーカー、患者の病歴を組み合わせたマルチモーダルAIモデルは、総合的な診断インサイトとパーソナライズされた治療推奨を生成する能力で脚光を浴びています。これらの進歩により、診断ツールは単一モダリティの精度を超えて、価値ベースのデータ駆動型医療をサポートする統合的精密診断へと押し上げられつつあります。

市場の需要はどこで加速し、どの臨床セグメントがAI診断の採用をリードしているか？

AIベースの医療診断ツールに対する需要は、米国、欧州、アジア太平洋全域で急速に拡大しています。これは、ヘルスケアのデジタル化の進展、AI統合に対する政策支援、臨床医の間での受け入れの拡大が背景にあります。北米は、先進的な医療ITインフラ、有利な償還パイロット、医療技術新興企業、学術機関、規制経路（FDAのAI/MLベースのSoftware as a Medical Deviceフレームワークなど）の活発なエコシステムに支えられ、導入でリードしています。欧州では、国の医療制度やEUが支援するイノベーション・プログラムを通じて導入が進んでいます。アジア太平洋では、中国、韓国、日本、インドなどの国々が、官民パートナーシップやAI中心のヘルスケア改革に後押しされ、病院や診断ラボでの導入を加速させています。

放射線学は依然として最も活発な応用分野であり、AIツールが診断の滞りに対処し、遠隔画像診断を可能にしています。病理学と腫瘍学は主要な成長分野であり、AIは腫瘍分類、変異プロファイリング、生検分析を支援しています。循環器内科では、心電図解釈、心不全リスク予測、画像ベースの構造評価にAIが活用されています。眼科と皮膚科では、糖尿病眼スクリーニングや皮膚病変分析にAIが導入されており、多くの場合モバイルやクラウドベースのソリューションが利用されています。感染症検出（COVID-19、結核など）やポイントオブケア診断における新たなアプリケーションは、臨床医不足が続く医療過疎地や農村部の医療環境にまで手を広げています。

AIベースの医療診断ツールの世界的成長の原動力は？

人工知能ベース医療診断ツールの成長の原動力は、ヘルスケアのデジタル化、慢性疾患負担の増加、タイムリーで費用対効果の高い診断を大規模に行う必要性の融合です。主要な促進要因は、構造化および非構造化臨床データの利用可能性の増加であり、クラウドコンピューティング、エッジAI、および連携学習の進歩と相まって、医療環境全体への安全でスケーラブルな展開を可能にしています。これらのツールは、診断ミスを減らし、臨床スループットを向上させ、早期介入を可能にします。

規制機関は、適応性のある承認経路、実臨床での検証要件、および市販後の性能モニタリングを通じて、AIの統合をサポートするように進化しています。AIツールはまた、EHR、PACS、遠隔医療プラットフォーム内に統合された臨床判断支援システム（CDSS）として支持を集めており、その使いやすさと臨床での採用が進んでいます。医療技術企業、支払者、医療提供者ネットワークが、集団健康、個別化医療、遠隔診療のためのAI診断への投資を増やすにつれ、極めて重要な疑問が浮上しています。AIベースの診断ツールは、タイムリーで正確な医療診断のための世界スタンダードを再定義するために、広範な臨床的信頼性、相互運用性、公平なアクセスを達成することができるでしょうか？

セグメント

コンポーネント（ソフトウェア、サービス、ハードウェア、メモリ、その他コンポーネント）;アプリケーション（放射線学、心臓病学、神経学、腫瘍学、その他アプリケーション）;バーティカル（病院、診断ラボ、その他バーティカル）

調査対象企業の例（全42件）

  • Ada Health
  • Aidmed
  • Aidoc
  • Aiforia
  • AliveCor
  • Bay Labs
  • Behold.ai
  • Butterfly Network
  • Caption Health
  • Cardiologs
  • Cleerly
  • DeepMind Health
  • Digital Diagnostics
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Ibex Medical Analytics
  • InferVision
  • Lunit
  • Medtronic

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP33471

Global Artificial Intelligence-based Medical Diagnostic Tools Market to Reach US$4.8 Billion by 2030

The global market for Artificial Intelligence-based Medical Diagnostic Tools estimated at US$1.7 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 19.0% over the analysis period 2024-2030. AI Software, one of the segments analyzed in the report, is expected to record a 19.6% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the AI Services segment is estimated at 17.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$445.7 Million While China is Forecast to Grow at 17.9% CAGR

The Artificial Intelligence-based Medical Diagnostic Tools market in the U.S. is estimated at US$445.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$739.3 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.4% and 16.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.9% CAGR.

Global Artificial Intelligence-Based Medical Diagnostic Tools Market - Key Trends & Drivers Summarized

Why Are AI-Based Diagnostic Tools Reshaping the Medical Decision-Making Landscape?

Artificial Intelligence-based medical diagnostic tools are transforming clinical workflows and healthcare delivery by providing fast, accurate, and scalable diagnostic support across a broad spectrum of medical disciplines. These tools leverage machine learning (ML), deep learning, and natural language processing (NLP) to analyze diverse clinical data-including radiology images, pathology slides, genomic sequences, electronic health records (EHRs), and laboratory test results-to identify patterns, detect anomalies, and generate differential diagnoses with greater consistency and speed than traditional methods. As healthcare systems worldwide grapple with rising patient volumes, workforce shortages, and the demand for precision medicine, AI-powered diagnostics are emerging as indispensable aids for improving diagnostic accuracy and reducing variability in care.

Unlike conventional decision-support systems that rely on static rule sets, AI tools continuously learn and evolve by training on large datasets, often annotated by experts, to provide real-time, evidence-based insights. These systems are being integrated into radiology suites, pathology labs, primary care practices, and telehealth platforms to support early disease detection, triage, and risk stratification. From oncology and cardiology to ophthalmology and dermatology, AI is enabling faster identification of complex conditions-reducing diagnostic delays, enhancing clinical productivity, and facilitating timely interventions that improve patient outcomes.

How Are AI Algorithms Enhancing Diagnostic Performance Across Imaging, Genomics, and Multimodal Data?

AI-based diagnostic tools are revolutionizing medical imaging by interpreting CT scans, MRIs, X-rays, mammograms, and ultrasound images with high precision. Deep convolutional neural networks (CNNs) are widely used for image segmentation, feature extraction, and lesion classification, often outperforming human specialists in specific tasks such as lung nodule detection, breast cancer screening, and diabetic retinopathy grading. These tools not only accelerate image interpretation but also highlight abnormalities with heat maps and explainability features that improve clinical confidence and workflow integration.

In genomics, AI is helping decode complex genetic data for disease risk prediction, rare disease diagnosis, and therapy selection in oncology. Natural language processing algorithms extract clinically relevant data from unstructured EHRs, lab reports, and clinical notes to create comprehensive patient profiles and detect diagnostic signals that may be missed in manual review. Multimodal AI models, which combine imaging, lab values, genetic markers, and patient history, are gaining prominence for their ability to generate holistic diagnostic insights and personalized treatment recommendations. These advances are pushing diagnostic tools beyond single-modality accuracy toward integrative precision diagnostics that support value-based, data-driven care.

Where Is Market Demand Accelerating and Which Clinical Segments Are Leading AI Diagnostic Adoption?

Demand for AI-based medical diagnostic tools is expanding rapidly across the U.S., Europe, and Asia-Pacific, driven by rising healthcare digitization, policy support for AI integration, and growing acceptance among clinicians. North America leads in adoption, supported by advanced health IT infrastructure, favorable reimbursement pilots, and an active ecosystem of medtech startups, academic institutions, and regulatory pathways (e.g., FDA’s AI/ML-based Software as a Medical Device framework). Europe is witnessing increased uptake through national health systems and EU-backed innovation programs. In Asia-Pacific, countries like China, South Korea, Japan, and India are accelerating deployment in hospitals and diagnostics labs, aided by public-private partnerships and AI-centric healthcare reforms.

Radiology remains the most active application area, where AI tools are addressing diagnostic backlogs and enabling teleradiology. Pathology and oncology are key growth segments, with AI aiding in tumor classification, mutation profiling, and biopsy analysis. Cardiology is leveraging AI for ECG interpretation, heart failure risk prediction, and imaging-based structural assessments. Ophthalmology and dermatology are deploying AI for diabetic eye screening and skin lesion analysis, often via mobile or cloud-based solutions. Emerging applications in infectious disease detection (e.g., COVID-19, TB) and point-of-care diagnostics are expanding reach into underserved and rural healthcare environments, where clinician shortages persist.

What Is Driving the Global Growth of AI-Based Medical Diagnostic Tools?

The growth in artificial intelligence-based medical diagnostic tools is driven by the convergence of healthcare digitalization, rising chronic disease burden, and the need for timely, cost-effective diagnostics at scale. A key driver is the increasing availability of structured and unstructured clinical data, coupled with advances in cloud computing, edge AI, and federated learning, which allow for secure, scalable deployment across care settings. These tools reduce diagnostic errors, improve clinical throughput, and enable earlier interventions-aligning with global goals of achieving better outcomes while reducing healthcare costs.

Regulatory bodies are evolving to support AI integration through adaptive approval pathways, real-world validation requirements, and post-market performance monitoring. AI tools are also gaining traction as clinical decision-support systems (CDSS) integrated within EHRs, PACS, and telehealth platforms-enhancing their usability and clinical adoption. As medtech companies, payers, and provider networks increasingly invest in AI diagnostics for population health, personalized medicine, and remote care, a pivotal question surfaces: Can AI-based diagnostic tools achieve widespread clinical trust, interoperability, and equitable access to redefine global standards for timely and precise medical diagnosis?

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence-based Medical Diagnostic Tools market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software, Services, Hardware, Memory, Other Components); Application (Radiology, Cardiology, Neurology, Oncology, Other Applications); Vertical (Hospitals, Diagnostic Laboratories, Other Verticals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Ada Health
  • Aidmed
  • Aidoc
  • Aiforia
  • AliveCor
  • Bay Labs
  • Behold.ai
  • Butterfly Network
  • Caption Health
  • Cardiologs
  • Cleerly
  • DeepMind Health
  • Digital Diagnostics
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Ibex Medical Analytics
  • InferVision
  • Lunit
  • Medtronic

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Artificial Intelligence-based Medical Diagnostic Tools - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Early Detection Capabilities Position AI Diagnostic Tools as Frontline Screening Technologies
    • Integration With Imaging Modalities Enhances Diagnostic Accuracy in Radiology and Pathology
    • AI-Based Tools Support Faster Triage and Clinical Decision-Making in Overburdened Healthcare Systems
    • Explainable AI Models Increase Physician Trust in Medical Diagnostic Algorithms
    • Expansion in Cloud-Based Platforms Drives Scalability of AI Diagnostic Tools Across Hospitals
    • Multi-Disease Screening Algorithms Enable Versatile Deployment of AI Medical Diagnostics
    • AI Integration Reduces Diagnostic Error Rates in Complex and Rare Disease Cases
    • Regulatory Approvals for AI Diagnostic Tools Expand Clinical Use in Primary and Secondary Care
    • Workflow Integration With EHRs and PACS Systems Boosts Adoption of AI Diagnostic Technologies
    • Consumer-Facing AI Tools Bridge Gaps in Access to Specialist Diagnostics
    • Telehealth Platforms Leverage AI Diagnostics for Real-Time Remote Evaluation
    • Cross-Specialty Application Potential Strengthens the Long-Term Value of AI-Based Diagnostic Tools
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence-based Medical Diagnostic Tools Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Memory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Memory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Verticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Verticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 66: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 84: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030

IV. COMPETITION